Clinical trial
B-cellspåverkan i Barn Till Kvinnor Med Multipel Skleros Och Rituximabbehandling före Eller Under Graviditeten (B-cell Effects in Children Born to Women With Multiple Sclerosis and Rituximab Treatment Before or During Pregnancy)
NCT07149662 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- B-cellspåverkan i Barn Till Kvinnor Med Multipel Skleros Och Rituximabbehandling före Eller Under Graviditeten (B-cell Effects in Children Born to Women With Multiple Sclerosis and Rituximab Treatment Before or During Pregnancy)
- Lead sponsor
- Region Stockholm
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- March 31, 2028
- Enrollment
- 111 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple sclerosis, pregnancy